Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.9.0
Dataset results
388 results for “immune checkpoint inhibitors”
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04615988. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
ClinicalTrials.gov study NCT06519292. IPD Sharing: NO. Countries: 1. Publications: 0.
Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04565769. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05349058. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT04974671. IPD Sharing: NO. Countries: 1. Publications: 0.
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
ClinicalTrials.gov study NCT06675643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.
ClinicalTrials.gov study NCT06923020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma
ClinicalTrials.gov study NCT04189679. IPD Sharing: NO. Countries: 1. Publications: 0.
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
ClinicalTrials.gov study NCT03469960. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
ClinicalTrials.gov study NCT05947669. IPD Sharing: YES. Countries: 2. Publications: 0.
Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
ClinicalTrials.gov study NCT06368141. IPD Sharing: NO. Countries: 1. Publications: 0.
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
ClinicalTrials.gov study NCT07090538. IPD Sharing: YES. Countries: 1. Publications: 0.
The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients
ClinicalTrials.gov study NCT05102773. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05055908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients
ClinicalTrials.gov study NCT06751108. IPD Sharing: NO. Countries: 1. Publications: 0.
Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment
ClinicalTrials.gov study NCT05813418. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
ClinicalTrials.gov study NCT05707286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
ClinicalTrials.gov study NCT03544723. IPD Sharing: NO. Countries: 1. Publications: 0.
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hep
ClinicalTrials.gov study NCT07368023. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer
ClinicalTrials.gov study NCT05284539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.